Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 Studied Ulcerative Colitis Research: Model Comparison

TNBS Colitis Intrarectal ethanol + TNBS Transmural, mixed Th1/Th17 7–14 days 10 mcg/kg IP daily Moderate. More Crohn's-like but validates mucosal healing Acetic Acid Colitis Intrarectal 4% acetic acid Superficial mucosal ulceration 5–10 days 10 mcg/kg IP or or

This comparison does not assign a generated winner or score.

  • TNBS Colitis
  • Intrarectal ethanol + TNBS
  • Transmural, mixed Th1/Th17
  • 7–14 days
  • 10 mcg/kg IP daily
  • Moderate. More Crohn's-like but validates mucosal healing
  • Acetic Acid Colitis
  • Intrarectal 4% acetic acid
  • Superficial mucosal ulceration
  • 5–10 days
  • 10 mcg/kg IP or oral
  • High. Closest to UC mucosal injury pattern
  • Cysteamine Model
  • Oral cysteamine 300 mg/kg
  • Duodenal ulcers, some colonic
  • 10–14 days
  • 10 ng/kg to 10 mcg/kg
  • Low. Primarily upper GI model
  • DSS (Dextran Sodium Sulfate)
  • 3–5% DSS in drinking water
  • Epithelial barrier disruption
  • 7–21 days (chronic)
  • Not extensively studied
  • Moderate. Chronic relapsing model but lacks immune memory
More references

Related material